FDA Pharmacogenomics Guidelines

The FDA's pharmacogenomics guidelines encourage the study of how individual genetics affect drug responses. By understanding these genetic variations, doctors can better tailor medications to patients, increasing efficacy and reducing side effects. The guidelines promote the inclusion of genetic information in drug labeling and support research on personalized medicine. This approach aims to improve patient outcomes by ensuring that treatments are more effective and safer, based on each person's unique genetic makeup. In essence, it advocates for a more customized approach to prescribing medications.